Supporters of President Donald Trump's health care pledges might be particularly vexed at the traditional benchmark of assessing the first 100 days in office for a new US president.
His early inflammatory comments on drug pricing controls sparked negative Wall Street reaction. But as he filled in his circle...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?